News

čeština/english

A decision of the Ministry of Health of the CR under the no. MZDR 33973/2019-2/CAU

MZCR 27. 06. 2022

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Celltrion Healthcare Hungary Kft. and AbbVie Deutschland GmbH & Co. KG, against the decision of the State Institute for Drug Control from 23. 5. 2019, under the no. SUKLS256885/2017:

  • the decision under appeal is partially reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz.

Back to news listing